Emergency: 911 Crisis: call or text 988 PA DDAP: 1-800-662-4357 PA 211: 2-1-1
24/7 Placement Advisors — Call (215) 792-4574

Meth Rehab in Philadelphia, PA

Stimulant deaths without opioids accounted for 15% of Philadelphia overdose fatalities in 2023 — and methamphetamine use continues to rise across the region, often alongside fentanyl-contaminated supply. Source: Philadelphia Health Dept.

Why Is Meth Use Rising in Philadelphia?

Methamphetamine has re-emerged as a significant substance in Philadelphia's drug supply over the past several years. Low prices, high potency (modern meth is predominantly crystal, manufactured at scale), and poly-drug overlap with fentanyl have driven meth-related overdose and treatment admissions upward. Many Philadelphia meth users also use opioids — meaning fentanyl contamination of the stimulant supply creates serious overdose risk even for those who do not consider themselves opioid users.

What Does Meth Rehab Look Like?

There is no FDA-approved medication specifically for methamphetamine use disorder. Treatment is primarily behavioral: cognitive behavioral therapy (CBT), contingency management (which has strong evidence for stimulant use disorder), motivational enhancement therapy, and relapse prevention. Inpatient treatment provides the structure, removal from using environment, and peer support that outpatient cannot match — particularly important in early recovery when meth withdrawal (severe fatigue, depression, anhedonia, intense cravings) is at its peak.

What Are Meth Withdrawal Symptoms?

Meth withdrawal is not medically dangerous in the way alcohol or benzodiazepine withdrawal can be — there are no seizure risks. However, the post-use 'crash' is severe: profound fatigue, depression, anhedonia (inability to feel pleasure), hyperphagia (intense hunger), and psychiatric symptoms including paranoia or psychosis in heavier users. These symptoms drive early relapse. Inpatient structure provides critical support through the first 1–2 weeks when cravings and depression are at their worst.

Dual Diagnosis and Meth

Co-occurring mental health conditions are particularly common in meth use disorder — ADHD, depression, bipolar disorder, and psychotic-spectrum conditions frequently coexist. Integrated dual diagnosis treatment addresses both the stimulant use disorder and the underlying mental health condition simultaneously, which produces significantly better outcomes than sequential treatment.

Does Insurance Cover Meth Rehab in PA?

Yes. Methamphetamine use disorder is a medically diagnosable condition covered by most commercial health plans under Pennsylvania Act 106 and federal parity law. Inpatient meth rehab and dual diagnosis treatment are covered as medically necessary services. Call (215) 792-4574 for a free insurance verification.

Ready to Talk? Call (215) 792-4574 — Available 24/7.

Free insurance verification in minutes. Most PPO plans cover inpatient rehab. Confidential, no obligation.

(215) 792-4574

Frequently Asked Questions

Is there a medication for meth addiction?

There is no FDA-approved medication specifically for methamphetamine use disorder. Treatment is primarily behavioral, with contingency management and CBT showing the strongest evidence. Research on pharmacological treatments continues, but inpatient treatment with evidence-based behavioral therapies and dual diagnosis care remains the clinical standard.

How long does meth withdrawal last?

The acute 'crash' phase typically lasts 1–2 weeks, with severe fatigue, depression, and anhedonia. Protracted withdrawal symptoms — including cravings and mood dysregulation — can persist for weeks to months. This is one reason extended inpatient stays (60–90 days) often produce better outcomes for meth use disorder.

Call Now